Maternal Health Market Size and Investment Trends
Maternal health market estimates vary wildly depending on what you're actually counting.
Women remain significantly underenrolled in clinical trials, leaving drugs dosed for male bodies.
Maternal health market estimates vary wildly depending on what you're actually counting.
NIH funding for women's health research lags disease burden by staggering margins.
Venture capital finally catches up to decades of neglected women's health research gaps.
Federal funding for women's health research has dropped sharply despite a larger overall budget.
Hospitals cut marketing budgets while demanding proof that spending actually converts patients.
A $600 billion market is reshaping how brands reach women through telehealth, influencers, and AI.
Women's health clinics command patient demand but lag in digital visibility—here's where to start.
How FemTech brands navigate FDA rules, algorithmic suppression, and deep mistrust.
Femtech founders should choose programs by stage, vertical fit, and actual investor access.
Mastering "intended use" and the three FDA pathways can cut years off your regulatory timeline.
Investors now demand clinical data and regulatory clarity even at the seed stage.